Status:
COMPLETED
Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Placental Vascular Pathologies
Venous Thromboembolism Diseases
Eligibility:
FEMALE
18-45 years
Brief Summary
The venous thromboembolism is one of the first causes of maternal mortality. Until 2003, only a few recommendations were available on the optimal use of antithrombotic therapy as a preventive measure ...
Detailed Description
Purpose : To create a score inspired by our first experience i.e. simple, standardized and quickly usable in day-to-day practice to individualize antithrombotics prescription to women at risk.
Eligibility Criteria
Inclusion
- multiparous or primiparous parturients followed in one of the participating centers
- Presenting at least one risk factor of venous thromboembolic pathology and/or placental vascular pathology
Exclusion
- parturient that can't be followed
- unknown familial or personal previous history
- Parturient with a contraindication to use of the treatment recommended by the therapeutic strategy
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
2280 Patients enrolled
Trial Details
Trial ID
NCT00745212
Start Date
June 1 2008
End Date
June 1 2013
Last Update
November 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Gynécologie Obstétrique - CHU Saint-Etienne
Saint-Etienne, France, 42055